Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma
Biogen posted strong Q4 results, surpassing estimates, while forecasting a 2025 revenue decline. The company secured up to ...
FiercePharma23h
FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls
A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. | The FDA ...
ENDPOINTS NEWS1d
FDA puts two Chi­nese API mak­ers on im­port alert af­ter failed in­spec­tions
Chinese API manufacturers Wuhu Nuowei Chemistry and Chengdu Innovation Pharmaceutical have been placed on US import alert ...
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ...
Mid-Day on MSN2d
Palghar drug bust: Police nab mastermind and three suppliers
In the Palghar drugs manufacturing case, three Mira Road residents were arrested by the Local Crime Branch (LCB) of Palghar ...
The US relies on China for key medicines. They won’t be spared from tariffs
President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...
ENDPOINTS NEWS5d
Bel­gian reg­u­la­tor rec­om­mends block­ing In­di­an drug­mak­er's API pro­duc­tion
Indian drugmaker Maithili Life Sciences has received a non-compliant report from the Brussels-based Federal Agency for ...